Items where authors include "Down, J."

Article

Harrop, R. orcid.org/0009-0006-2743-6842, Blount, D.G. orcid.org/0009-0008-7145-0478, Khan, N. orcid.org/0000-0002-1433-8454 et al. (11 more authors) (2025) Targeting the tumour antigen 5T4 using CAR-T cells for the treatment of Acute Myeloid Leukaemia. Molecular Cancer Therapeutics, 24 (1). pp. 93-104. ISSN 1535-7163

Griffin, J. orcid.org/0000-0003-3969-7637, Down, J., Quayle, L.A. et al. (10 more authors) (2024) Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial. The Journal of Pathology: Clinical Research, 10 (2). e12363. ISSN 2056-4538

Müller, L.M.E., Migneco, G., Scott, G.B. et al. (17 more authors) (2021) Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer, 9 (3). e001803. ISSN 2051-1426

Chinnaiya, K., Lawson, M.A. orcid.org/0000-0002-5446-923X, Thomas, S. orcid.org/0000-0002-0027-0815 et al. (8 more authors) (2017) Low-dose methotrexate in myeloproliferative neoplasm models. Haematologica, 102 (6). 165738. ISSN 0390-6078

Lawson, M.A., McDonald, M.M., Kovacic, N. et al. (18 more authors) (2015) Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. Nature Communications, 6. 8983.

Rehman, I., Evans, C.A., Glen, A. et al. (9 more authors) (2012) iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer. PLoS ONE, 7 (2). e30885. ISSN 1932-6203

Proceedings Paper

Crabb, S.J., Hussain, S.A., Oughton, J.B. et al. (15 more authors) (2024) Use of gene expression patterns to identify unique molecular subtypes in muscle invasive bladder cancer: GUSTO. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .

Jiang, Y., Down, J., Raffles, S. et al. (6 more authors) (2018) Targeting free light chain (FLC) secretion and the unfolded protein response in myeloma cells using VaN, a combination of repurposed drugs. In: Experimental Hematology. 47th Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology, 23-26 Aug 2018, Los Angeles, USA. Elsevier , S74-S75.